Roivant Sciences Ltd. (NasdaqGS: ROIV)
Health Care · Biotechnology · GB
$35.27
-0.49% today · +119.9% 1Y
Roivant Sciences Ltd. (NasdaqGS: ROIV) operates in the Biotechnology industry within the Health Care sector. The company is valued at $25.60B and employs 721 people.
Over the last twelve months the share price has gained 119.9%, trading between 15.90 and 42.50.
Tweenvest scores Roivant Sciences Ltd. across four factors: quality 40/100, value 71/100, growth 0/100. Its strongest factor is value.
ROIV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $25.60B
- Revenue (TTM)
- $7.53M
- P/E
- —
- EPS
- -0.49
- Dividend yield
- —
- Beta (5Y)
- 1.10
- 52-week high
- $42.50
- 52-week low
- $15.90
- Avg volume (3M)
- —
- Shares outstanding
- 722.32M
- Employees
- 721
- Next earnings
- —
About Roivant Sciences Ltd.
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
- ISIN
- BMG762791017
- Founded
- 2014
- Listed since
- Dec 8, 2020
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BeOne Medicines AGNasdaqGS: ONC | $40.30B | $354.47 | +1.24% |
| Biogen Inc.NasdaqGS: BIIB | $33.35B | $234.64 | +3.95% |
| Alnylam Pharmaceuticals, Inc.NasdaqGS: ALNY | $31.13B | $229.87 | -1.21% |
| Celltrion, Inc.KOSE: A068270 | $30.52B | ₩179,600.00 | -1.64% |
| BioNTech SENasdaqGS: BNTX | $24.36B | $96.93 | -0.03% |
| United Therapeutics CorporationNasdaqGS: UTHR | $23.55B | $552.03 | +0.52% |
| Incyte CorporationNasdaqGS: INCY | $22.86B | $112.99 | +0.18% |
| Insmed IncorporatedNasdaqGS: INSM | $21.97B | $99.63 | -0.96% |
Figures last refreshed Oct 11, 2026.